On September 28, 2021 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs, reported that it will present at the Cantor Fitzgerald Virtual Global Healthcare Conference, which is being held from September 27th to 30th (Press release, Actinium Pharmaceuticals, SEP 28, 2021, View Source [SID1234590397]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Event:

Cantor Fitzgerald Virtual Global Healthcare Conference

Date:

Wednesday, September 29th

Time:

3:20 p.m. ET

Webcast:

The presentation will be accessible on the investor relations section of Actinium Pharmaceuticals website at www.actiniumpharma.com.

In addition, members of the executive team will be available for one-on-one meetings with conference attendees. Those interested in scheduling a meeting may do so by contacting their Cantor Fitzgerald representative.